Literature DB >> 2474787

c-kit mRNA expression in human and murine hematopoietic cell lines.

C André1, L d'Auriol, C Lacombe, S Gisselbrecht, F Galibert.   

Abstract

The c-kit proto-oncogene belongs to the tyrosine kinase receptor family. Although its ligand is still unknown, there is increasing evidence to suggest its involvement in hematopoiesis. In order to detect lineage or differentiation related specificity, we have studied c-kit mRNA expression in both human and murine hematopoietic organs and cell lines. We show that c-kit mRNA expression is found at early stages of erythroid and myeloid differentiation. There is however, no evidence of c-kit expression in the lymphoid lineage. Our results suggest a possible role for c-kit as a receptor in the early stages of the erythroid/myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474787

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Stem cells, phenotypic inversion, and differentiation.

Authors:  Robert W Siggins; Ping Zhang; David Welsh; Nicole J Lecapitaine; Steve Nelson
Journal:  Int J Clin Exp Med       Date:  2008-01-20

2.  Deletion of the c-kit protooncogene in the human developmental defect piebald trait.

Authors:  R A Fleischman; D L Saltman; V Stastny; S Zneimer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.

Authors:  L B Giebel; R A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Modulation of c-kit mRNA and protein by hemopoietic growth factors.

Authors:  M J Welham; J W Schrader
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Authors:  T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; U Koshimizu; H Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

Authors:  T Kitoh; H Ishikawa; S Sawada; K Koshino; Y Tokano; H Hashimoto; S Nakagawa
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.

Authors:  R A Fleischman
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.

Authors:  M Z Ratajczak; J A Kant; S M Luger; N Hijiya; J Zhang; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues.

Authors:  Y Tsuura; H Hiraki; K Watanabe; S Igarashi; K Shimamura; T Fukuda; T Suzuki; T Seito
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Phosphatidylinositol 3'-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex.

Authors:  M S Shearman; R Herbst; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.